4.7 Article

Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia

期刊

EUROPEAN JOURNAL OF CANCER
卷 142, 期 -, 页码 10-17

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2020.10.013

关键词

Melanoma brain; metastasis; Guidelines; Systemic therapy; Surgery; Radiation therapy

类别

资金

  1. Skin Cancer College Australasia
  2. Australasian College of Dermatologists

向作者/读者索取更多资源

The brain is a common site of metastatic disease for patients with advanced melanoma, with treatment approaches including surgery, radiotherapy, and systemic therapy. Management of melanoma brain metastases should involve a multidisciplinary team and consider optimal combinations and sequencing of treatments. It is important to establish appropriate guidelines for the management of melanoma brain metastases and update them regularly as new treatment options become available.
Introduction: The brain is a common site of metastatic disease for patients with advanced melanoma. Brain metastasis portends a poor prognosis, often causing deterioration in neurological function and quality of life, and leading to neurological death. Treatment approaches including surgery, radiotherapy and systemic therapy can lead to better control of this problem. Therefore, appropriate guidelines for the management of melanoma brain metastases need to be established, with regular updating when new treatment options become available. Methods: A multidisciplinary working party established by Cancer Council Australia has produced up-to-date, evidence-based clinical practice guidelines for the management of melanoma. After selecting key clinical questions, a comprehensive literature search for relevant studies was conducted, followed by systematic review of those studies. Data were summarised and the evidence was assessed, leading to the development of recommendations. Main recommendations: Symptomatic lesions are best treated with surgery, when possible; this provides safe and effective local control. For patients with single or a small number of asymptomatic brain metastases, stereotactic radiotherapy is recommended, but in asymptomatic patients who have not previously received systemic treatment, drug therapy can be considered as a first-line treatment option. Whole brain radiotherapy may provide palliative benefits in patients with multiple brain metastases. Whenever possible, melanoma patients with brain metastases should be managed by a multidisciplinary team of melanoma specialists that considers the optimal combination and sequencing of surgery, radiotherapy and systemic therapy. Crown Copyright (C) 2020 Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据